Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT00761475
Other study ID # PRIMA TRIAL
Secondary ID
Status Completed
Phase Phase 3
First received September 26, 2008
Last updated October 27, 2016
Start date February 2009
Est. completion date April 2015

Study information

Verified date October 2016
Source Erasmus Medical Center
Contact n/a
Is FDA regulated No
Health authority Netherlands: The Central Committee on Research Involving Human Subjects (CCMO)
Study type Interventional

Clinical Trial Summary

Incisional hernia is the most frequently seen long term complication in surgery causing much morbidity and even mortality in patients. Despite studies on the optimal closing technique for laparotomies, the risk for incisional hernia after midline incision remains about 5-20 %. Major risk factors for incisional hernia after a laparotomy, like obesity, steroid use, malnutrition, smoking and connective tissue disorders, are known. Despite this knowledge, there has not yet been developed a sufficient method for prevention. One specific group of high risk patients are patients with an abdominal aortic aneurysm (AAA). The relationship between aortic aneurysm and other abdominal wall hernias, like inguinal hernias, has been reported. Retrospective and prospective studies have shown an average risk for incisional hernia after AAA repair of 31.6 %. Another high risk group is the group of obese patients. Patients with a BMI of more than 27 have a high risk of developing an incisional hernia after midline incision with an incidence of 22% after 12 months. Considering only 50 % of incisional hernia will be clinically evident in the first 12 months, the total incidence will be above 30%. This high risk group of patients with obesitas and aneurysmatic disease can benefit most from prevention. Some small studies have been performed to evaluate the usefulness and safety of primary laparotomy wound closure with the aid of prosthetic mesh. These studies show a very low risk for incisional hernias and a low infection rate, even when used in contaminated wounds such as colostomal surgery. However, there has not been performed an adequate randomized controlled trial to study the prevention of incisional hernias. Our hypothesis is that incisional hernia prevention with use of prosthetic mesh after laparotomy is effective in patients with aortic aneurysm and in obese patients with a BMI of more than 27.


Recruitment information / eligibility

Status Completed
Enrollment 480
Est. completion date April 2015
Est. primary completion date December 2012
Accepts healthy volunteers No
Gender Both
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Every elective midline laparotomy for patients with Abdominal Aortic Aneurysm and patients with a BMI of more than 27.

- Signed informed consent

Exclusion Criteria:

- Age < 18 years

- Emergency procedure

- Inclusion in other trials

- Aortic reconstruction for obstructive disease

- Life expectancy less than 24 months

- Pregnant women

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Outcomes Assessor), Primary Purpose: Prevention


Related Conditions & MeSH terms


Intervention

Procedure:
mesh supported closure
onlay mesh supported closure midline laparotomy
primary closure
primary closure of the midline
mesh supported closure
sublay mesh supported closure midline laparotomy

Locations

Country Name City State
Austria Wilhelminenspital Vienna
Germany Berlin-Charite Universitatsklinikum Berlin
Germany Hamburg-Eppefdorf Universitatsklinikum Hamburg
Germany Heidelberg University Medical Center Heidelberg
Germany Munchen University Medical Center Munchen
Netherlands IJsselland Ziekenhuis Capelle a/d IJssel
Netherlands Scheper Ziekenhuis Emmen
Netherlands Erasmus Medical Center Rotterdam Zuid-Holland
Netherlands Maasstad Ziekenhuis Rotterdam
Netherlands Sint Franciscus Gasthuis Rotterdam
Netherlands Maxima Medisch Centrum Veldhoven
Netherlands Isala klinieken Zwolle

Sponsors (3)

Lead Sponsor Collaborator
Erasmus Medical Center Aesculap AG, Baxter Healthcare Corporation

Countries where clinical trial is conducted

Austria,  Germany,  Netherlands, 

Outcome

Type Measure Description Time frame Safety issue
Primary incisional hernia occurence 2 years No
Secondary complications 1 month No
Secondary post-operative pain 1 month No
Secondary quality of life 2 years No